FL S1412 | 2012 | Regular Session

Status

Completed Legislative Action
Spectrum: Partisan Bill (Republican 1-0)
Status: Failed on March 9 2012 - 100% progression
Action: 2012-03-09 - Died in Health Regulation
Text: Latest bill text (Introduced) [HTML]

Summary

Citing this act as the "Prescription Drug Access and Pricing Protection Act"; prohibiting a person engaged in distribution of prescription drugs from selling prescription drugs below wholesale cost to a pharmacy provider at an outlet if such sale injures competition; prohibiting a prescription drug wholesaler or distributor from selling a prescription drug to a retail pharmacy at a price that is below the price charged by the wholesaler or distributor under written contract of a like brand and quality of the prescription drug under certain circumstances; prohibiting a person engaged in distributing prescription drugs from reselling or knowingly receiving for resale any prescription drugs at a price lower than the price at which the seller contemporaneously sells prescription drugs of like brand and quality to another retail outlet on the same level of distribution, in the same class of trade, and within the same relevant geographic market as the purchaser, etc.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription Drugs

Sponsors


History

DateChamberAction
2012-03-09 Died in Health Regulation
2012-01-13 Introduced -SJ 152
2012-01-13 Referred to Health Regulation; Judiciary; Budget -SJ 152
2012-01-03 Filed

Florida State Sources


Bill Comments

feedback